Pharmacist Management of Paxlovid eVisits

Completed · Not applicable

Conditions studied: COVID-19, Quality of Care

In brief

The goal of this cluster randomized trial is to compare two modes of management -- pharmacist care vs. pooled adult and family medicine physician care -- for electronically submitted requests (e-visits) for Paxlovid by adults with COVID-19. It will compare quality of care based on counseling for common potential drug-drug interactions and time to prescription, as well as the time and financial costs of care in the two groups.

Key facts

Study ID

NCT06076863

Run by

Kaiser Permanente

People needed

2478

Starts

2023-10-09

Expected to finish

2024-01-11

Last updated by the study team

2024-03-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients making Paxlovid e-visits on weekdays from 8:00 am to 4:30 pm during the study period

You may not qualify if…

• None

Where it is running

• Kaiser Permanente Northern California — Oakland, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.